Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Macrophage activation syndrome (MAS) is a subset of hemophagocytic lymphohistiocytosis (HLH) described in patients with rheumatological disorders. Some triggers of MAS and HLH include infection, malignancy, rheumatological disease, HIV, and rarely medications such as immunosuppressants. In recent medical literature, biologic agents are increasingly recognized as a potential trigger, but the mechanism behind this remains poorly understood. We describe the case of a patient who developed MAS after initiating adalimumab and propose a potential pathophysiological link between biologics and this syndrome.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899127PMC
http://dx.doi.org/10.7759/cureus.12825DOI Listing

Publication Analysis

Top Keywords

macrophage activation
8
activation syndrome
8
syndrome initiation
4
initiation adalimumab
4
adalimumab patient
4
patient longstanding
4
longstanding rheumatoid
4
rheumatoid arthritis
4
arthritis macrophage
4
syndrome mas
4

Similar Publications

Postmenopausal osteoporosis (PMOP) is a common bone metabolic disorder in middle-aged and elderly women, yet its pathogenesis remains unclear. This study investigates the effect of nuclear factor erythroid 2-related factor 2 (Nrf2) deficiency on bone homeostasis to provide insight into the mechanisms underlying PMOP. Sixteen female SD rats were randomly assigned to Sham and ovariectomized (OVX) groups.

View Article and Find Full Text PDF

Melanoma is a malignant neoplasm with a high propensity to metastasize, arising from melanocytes and contributing significantly to global morbidity and mortality. Despite the demonstrated efficacy of many immunotherapy approaches, these methods rely on direct destruction of tumor cells with minimal impact on the aggregate of nearby non-tumor cells, the extracellular matrix, and blood vessels that form the tumor microenvironment (TME). The TME is known to be heterogeneous and dynamic, exerting both antitumor and pro-tumor effects depending on the specific features and stage of carcinogenesis.

View Article and Find Full Text PDF

Objective: Endotoxin tolerance (ET) has been demonstrated to attenuate the inflammatory response in murine models of sepsis. This study seeks to elucidate the underlying mechanisms by which ET modulates inflammation in sepsis, with a particular focus on macrophage autophagy.

Methods: An sepsis model was generated using cecal ligation and perforation, while an model of inflammatory injury was induced via lipopolysaccharide (LPS) administration.

View Article and Find Full Text PDF

Objective: Enterovirus 71 (EV-A71) is a major pathogen of severe hand, foot and mouth disease (HFMD) in children, but the mechanism by which it develops into severe HFMD remains unclear, especially the role of macrophage-mediated immune dysregulation.

Methods: Bioinformatics tools were utilized to analyze the transcriptome sequencing results of peripheral blood monocytes (PBMCs) infected with different titers of EV-A71 at various time points. Single-cell sequencing technology was used to sequence obtained PBMCs from a severe HFMD patient due to EV-A71 and a healthy control.

View Article and Find Full Text PDF

Peripheral nerve injury-induced muscle atrophy is characterized by chronic inflammation and dysregulated macrophage polarization. RUNX1, a transcription factor upregulated in denervated muscle, has been implicated in linking muscle degeneration to inflammatory processes, but its downstream targets and mechanisms remain unclear. The aim of this study is to delineate the RUNX1-JUNB-NF-κB axis in driving inflammation-mediated muscle atrophy.

View Article and Find Full Text PDF